| Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents C Hoffmann, S Dollive, S Grunberg, J Chen, H Li, GD Wu, JD Lewis, ... PloS one 8 (6), e66019, 2013 | 868 | 2013 |
| Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment S Dollive, YY Chen, S Grunberg, K Bittinger, C Hoffmann, L Vandivier, ... PloS one 8 (8), e71806, 2013 | 236 | 2013 |
| A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples S Dollive, GL Peterfreund, S Sherrill-Mix, K Bittinger, R Sinha, C Hoffmann, ... Genome biology 13, 1-13, 2012 | 159 | 2012 |
| Sustained correction of a murine model of phenylketonuria following a single intravenous administration of AAVHSC15-PAH SS Ahmed, H Rubin, M Wang, D Faulkner, A Sengooba, SN Dollive, ... Molecular Therapy-Methods & Clinical Development 17, 568-580, 2020 | 18 | 2020 |
| Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15 HM Chen, R Resendes, A Ghodssi, D Sookiasian, M Tian, S Dollive, ... Plos one 15 (5), e0233373, 2020 | 11 | 2020 |
| Adeno-associated virus compositions for PAH gene transfer and methods of use thereof AB Seymour, SS Ahmed, JB Wright, SN Dollive, H Rubin US Patent 10,610,606, 2020 | 6 | 2020 |
| Pilze im Darm–das Mykobiom des Darms H Hof Zeitschrift für Gastroenterologie 55 (08), 772-778, 2017 | 4 | 2017 |
| Dynamics of microeukaryotes and archaea in the mammalian gut microbiome S Dollive University of Pennsylvania, 2013 | 2 | 2013 |
| Analytical characterization of full, intermediate, and empty AAV capsids A McColl-Carboni, S Dollive, S Laughlin, R Lushi, M MacArthur, S Zhou, ... Gene Therapy, 1-10, 2024 | 1 | 2024 |
| Adeno-associated virus compositions for PAH gene transfer and methods of use thereof AB Seymour, SS Ahmed, JB Wright, SN Dollive, H Rubin US Patent 11,951,183, 2024 | | 2024 |
| Bidirectional dual promoter expression vectors and uses thereof C Barnes, Y Sharma, O Francone, H Rubin, W Wang, G Cerqueira, ... US Patent App. 18/182,001, 2023 | | 2023 |
| Non-naturally occurring polyadenylation elements and methods of use thereof SN Dollive, A Pla US Patent App. 17/932,961, 2023 | | 2023 |
| Adeno-associated virus compositions and methods of use thereof SN Dollive US Patent App. 17/806,409, 2023 | | 2023 |
| Adeno-associated virus compositions for restoring pah gene function and methods of use thereof AB Seymour, SS Ahmed, JB Wright, SN Dollive, JA McSwiggen, JM Prout, ... US Patent App. 17/656,562, 2022 | | 2022 |
| Vectorized antibodies and uses thereof C Barnes, Y Sharma, S Dollive, O Francone US Patent App. 17/447,231, 2022 | | 2022 |
| Adeno-associated virus compositions for ids gene transfer and methods of use thereof J Gingras, K Patel, LJ Smith, Y White, SN Dollive, L Van Lieshout, ... US Patent App. 17/222,659, 2021 | | 2021 |
| Blood-brain-barrier crossing leads to long term efficacy in the CNS of HMI-203: Gene therapy development candidate for Mucopolysaccharidosis Type II (MPS II), or Hunter Syndrome L Smith, K Patel, J Gingras, A Tzianabos, T Seabrook, M Kivaa, ... HUMAN GENE THERAPY 32 (19-20), A52-A52, 2021 | | 2021 |
| Gene therapy-mAb platform targets Complement Protein 5 using AAVHSCs Y Sharma, H Rubin, N Avila, M Scarpitti, J Lotterhand, A Hayes, D Rappoli, ... HUMAN GENE THERAPY 32 (19-20), A75-A76, 2021 | | 2021 |
| Adeno-associated virus compositions for restoring pah gene function and methods of use thereof AB Seymour, SS Ahmed, JB Wright, SN Dollive, JA McSwiggen, JM Prout, ... US Patent App. 17/073,862, 2021 | | 2021 |
| Long-Term Expression of HMI-203: Investigational Gene Therapy Candidate for Mucopolysaccharidosis Type II (MPS II), or Hunter Syndrome L Smith, K Patel, J Gingras, A Tzianabos, L Schulman, V Zhivich, M Kivaa, ... MOLECULAR THERAPY 29 (4), 247-247, 2021 | | 2021 |
